Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability

Open Access

Peer-reviewed

Research Article

Sofie Trier,

Affiliations Dept. of Micro- and Nanotechnology, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, Denmark, Diabetes Research Unit, Novo Nordisk, Maaloev, Denmark
⨯
Lars Linderoth,

Affiliation Diabetes Research Unit, Novo Nordisk, Maaloev, Denmark
⨯
Simon Bjerregaard,

Affiliation Diabetes Research Unit, Novo Nordisk, Maaloev, Denmark
⨯
Thomas Lars Andresen,

Affiliation Dept. of Micro- and Nanotechnology, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, Denmark
⨯
Ulrik Lytt Rahbek

* E-mail: ulyr@novonordisk.com

Affiliation Diabetes Research Unit, Novo Nordisk, Maaloev, Denmark
⨯

Reader Comments (0)

Cell membranes
Is the Subject Area "Cell membranes" applicable to this article?

Thanks for your feedback.
Acylation
Is the Subject Area "Acylation" applicable to this article?

Thanks for your feedback.
Gastrointestinal tract
Is the Subject Area "Gastrointestinal tract" applicable to this article?

Thanks for your feedback.
Liposomes
Is the Subject Area "Liposomes" applicable to this article?

Thanks for your feedback.
Cell binding
Is the Subject Area "Cell binding" applicable to this article?

Thanks for your feedback.
Lipids
Is the Subject Area "Lipids" applicable to this article?

Thanks for your feedback.
Permeability
Is the Subject Area "Permeability" applicable to this article?

Thanks for your feedback.
Drug interactions
Is the Subject Area "Drug interactions" applicable to this article?

Thanks for your feedback.